Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tricyclic Diterpenoids Selectively Suppress Androgen Receptor-Positive Prostate Cancer Cells

Molecules(2023)10.3390/molecules28124743Source: DataRank Database

Tricyclic Diterpenoids Selectively Suppress Androgen Receptor-Positive Prostate Cancer Cells is a research paper published in Molecules (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 1.16)OA: goldTopics (61)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Guanglin Chen ORCID,Keyara Piri ORCID,Seiji Shinkawa ORCID,Dennis Ashong ORCID,Qiang Zhang ORCID

Live enrichment

PubMed:37375297 PMC:PMC10300971 OpenAlex:https://openalex.org/W4380684729

California State University

Grant: G12MD007595

California State University

Grant: R25GM131956

California State University

Grant: HRD-1826490

California State University

Grant: T32GM137948

NIMHD NIH HHS

Grant: U54 MD007595

National Science Foundation

Grant: 1826490

Louis Stokes STEM Pathways and Research Alliance (CSU-LSAMP)

National Institutes of Health

Grant: 5R25GM131956-05

Fresno State RISE Program

National Institutes of Health

Grant: 5T32GM137948-04

Bridges to Doctorate Program between Fresno State and UC Davis

National Institutes of Health

Grant: 2G12MD007595-06

Collaborations and Partnerships

California State University

FWCI

1.16

Citation Percentile

0.8%

Influential Citations

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1420-3049/28/12/4743/pdf?version=1686657290

GOLDhttps://www.mdpi.com/1420-3049/28/12/4743/pdf?version=1686657290

publisherhttps://www.mdpi.com/1420-3049/28/12/4743/pdf?version=1686657290

publisherhttps://www.mdpi.com/1420-3049/28/12/4743/pdf

journalhttps://doi.org/10.3390/molecules28124743

Fields of Study

Prostate Cancer Treatment and ResearchUbiquitin and proteasome pathwaysBiological Activity of Diterpenoids and BiflavonoidsMedicineChemistry01 natural sciences0104 chemical sciencesMaleHumansReceptors, AndrogenProstatic Neoplasms, Castration-ResistantCell Line, TumorAndrogen Receptor AntagonistsDiterpenesBenzamidesNitrilesPhenylthiohydantoin

MeSH Terms

BenzamidesDiterpenesHumansMaleNitrilesPhenylthiohydantoinReceptors, AndrogenCell Line, TumorAndrogen Receptor AntagonistsProstatic Neoplasms, Castration-Resistant

Keywords

LNCaPEnzalutamideAndrogen receptorDU145Prostate cancerChemistryPotencyPharmacologyCancer researchCancerTricyclicStereochemistryBiochemistryInternal medicineMedicineIn vitroDiterpenoidN-terminal domainAndrogen Receptor AntagonistQw07MaleOrganic chemistryArticle<i>N</i>-terminal domainProstatic Neoplasms, Castration-ResistantQD241-441Receptors, AndrogenCell Line, TumorBenzamidesNitrilesPhenylthiohydantoinAndrogen Receptor AntagonistsHumansDiterpenes

Sustainable Development Goals

SDG 0: Good health and well-being